StockNews.com upgraded shares of Joint (NASDAQ:JYNT – Free Report) from a hold rating to a buy rating in a research report report published on Friday morning.
Separately, Roth Mkm decreased their target price on shares of Joint from $16.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, November 8th.
View Our Latest Research Report on JYNT
Joint Stock Performance
Hedge Funds Weigh In On Joint
A number of hedge funds have recently added to or reduced their stakes in JYNT. FMR LLC lifted its stake in Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company’s stock valued at $123,000 after acquiring an additional 2,971 shares during the last quarter. Squarepoint Ops LLC bought a new position in shares of Joint during the 2nd quarter valued at $144,000. Sargent Investment Group LLC bought a new position in shares of Joint during the 2nd quarter valued at $150,000. XTX Topco Ltd acquired a new stake in shares of Joint in the 2nd quarter valued at $174,000. Finally, Price T Rowe Associates Inc. MD boosted its holdings in Joint by 5.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock worth $229,000 after purchasing an additional 837 shares in the last quarter. Institutional investors and hedge funds own 76.88% of the company’s stock.
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Articles
- Five stocks we like better than Joint
- What is Put Option Volume?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Breakout Stocks: What They Are and How to Identify Them
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- What is the Nasdaq? Complete Overview with History
- Time to Load Up on Home Builders?
Receive News & Ratings for Joint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Joint and related companies with MarketBeat.com's FREE daily email newsletter.